End-of-day quote
Shenzhen S.E.
06:00:00 2024-07-02 pm EDT
|
5-day change
|
1st Jan Change
|
8.95
CNY
|
-0.44%
|
|
+4.92%
|
-20.59%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,802
|
2,367
|
4,141
|
2,580
|
2,318
|
1,841
|
-
|
-
|
Enterprise Value (EV)
1 |
1,802
|
2,367
|
4,141
|
2,580
|
2,318
|
1,841
|
1,841
|
1,841
|
P/E ratio
|
-
|
17.9
x
|
27.6
x
|
22.4
x
|
38.9
x
|
25.2
x
|
21.8
x
|
18.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.24
x
|
2.63
x
|
3.47
x
|
2.39
x
|
2.49
x
|
1.81
x
|
1.65
x
|
1.55
x
|
EV / Revenue
|
2.24
x
|
2.63
x
|
3.47
x
|
2.39
x
|
2.49
x
|
1.81
x
|
1.65
x
|
1.55
x
|
EV / EBITDA
|
-
|
12.7
x
|
19.4
x
|
15.3
x
|
22.4
x
|
14.5
x
|
12.5
x
|
10.7
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
-
|
2.57
x
|
4.09
x
|
2.41
x
|
2.18
x
|
1.67
x
|
1.62
x
|
1.56
x
|
Nbr of stocks (in thousands)
|
203,813
|
203,800
|
205,735
|
205,735
|
205,716
|
205,716
|
-
|
-
|
Reference price
2 |
8.843
|
11.61
|
20.13
|
12.54
|
11.27
|
8.950
|
8.950
|
8.950
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/24/22
|
2/20/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
804.9
|
900.3
|
1,193
|
1,078
|
929.8
|
1,016
|
1,113
|
1,188
|
EBITDA
1 |
-
|
186.9
|
213.1
|
168.3
|
103.5
|
127
|
147.4
|
172.3
|
EBIT
1 |
-
|
155.1
|
175.3
|
134.8
|
62.01
|
86.02
|
97.85
|
114.4
|
Operating Margin
|
-
|
17.23%
|
14.7%
|
12.5%
|
6.67%
|
8.47%
|
8.79%
|
9.63%
|
Earnings before Tax (EBT)
1 |
-
|
149.6
|
167.8
|
128
|
61.63
|
80.86
|
93.18
|
110.2
|
Net income
1 |
96.85
|
137.3
|
154.8
|
119.3
|
60.51
|
76.17
|
87.22
|
103.5
|
Net margin
|
12.03%
|
15.25%
|
12.98%
|
11.06%
|
6.51%
|
7.5%
|
7.84%
|
8.72%
|
EPS
2 |
-
|
0.6500
|
0.7300
|
0.5600
|
0.2900
|
0.3550
|
0.4100
|
0.4850
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/24/22
|
2/20/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
15.2%
|
15.5%
|
11.1%
|
5.51%
|
6.6%
|
7.35%
|
8.36%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
5.23%
|
5.6%
|
6.2%
|
7.3%
|
Assets
1 |
-
|
-
|
-
|
-
|
1,157
|
1,360
|
1,407
|
1,418
|
Book Value Per Share
2 |
-
|
4.520
|
4.920
|
5.190
|
5.180
|
5.360
|
5.530
|
5.760
|
Cash Flow per Share
2 |
-
|
0.5300
|
0.8000
|
0.6000
|
0.3800
|
1.340
|
-0.2300
|
1.480
|
Capex
1 |
-
|
49.7
|
62
|
18.4
|
61.9
|
89.8
|
93.3
|
89.3
|
Capex / Sales
|
-
|
5.52%
|
5.2%
|
1.71%
|
6.65%
|
8.83%
|
8.38%
|
7.52%
|
Announcement Date
|
2/27/20
|
2/25/21
|
2/24/22
|
2/20/23
|
2/23/24
|
-
|
-
|
-
|
Last Close Price
8.95
CNY Average target price
10.28
CNY Spread / Average Target +14.92% Consensus |
1st Jan change
|
Capi.
|
---|
| -20.59% | 254M | | +18.91% | 67.29B | | -6.54% | 45.32B | | +23.68% | 43.72B | | +37.17% | 28.07B | | +9.03% | 19.24B | | +15.11% | 17.22B | | -26.04% | 14.64B | | -13.27% | 14.51B | | -29.84% | 11.58B |
Other Specialty Chemicals
|